Plasma p‐tau217 Versus p‐tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease‐Related Neurostructural Changes and Cognitive Function
Movement Disorders · 15.06.2026
DOI: 10.1002/mds.70392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 15.06.2026. Verfasst von Eleonora Fiorenzato und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegenerative Disease Unit, Department of Neuroscience, Padua Neuroscience Center (PNC), University of Padua, Padua, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, National Recovery and Resilience Plan (NRRP)., NextGenerationEU (DM 1557 11.10.2022)..
Themen: Demenz
Abstract (Originalsprache)
Background
Plasma phosphorylated‐tau at threonine‐217 (p‐tau217) and threonine‐181 (p‐tau181) are scalable, minimally invasive biomarkers of Alzheimer's disease (AD) pathology. In Parkinson's disease (PD), AD co‐pathology may contribute to its clinical heterogeneity. However, the existing literature has predominantly focused on p‐tau181, with comparatively limited investigation of p‐tau217.
Objective
The aim is to evaluate plasma p‐tau217 and p‐tau181 as biomarkers of AD co‐pathology across the PD cognitive spectrum, relative to a cohort of dementia‐free older adults.
Methods
Plasma p‐tau217 and p‐tau181 were measured in 70 PD patients and 83 older adults. Associations with cognitive impairment, disease severity (Hoehn‐and‐Yahr), and neurostructural measures—including global atrophy, hippocampal volume, and a magnetic resonance imaging‐based AD signature—were assessed using correlation and dominance analyses.
Results
Both p‐tau217 and 181 were higher in PD with cognitive impairment and dementia compared with cognitively normal PD. P‐tau217 showed stronger associations than p‐tau181 with AD‐like neurostructural changes, multidomain cognitive deficits, greater disease severity, and reduced functional independence.
Conclusions
Plasma p‐tau217 and p‐tau181 may serve as scalable markers of AD‐related processes associated with neurostructural, clinical, and cognitive outcomes in PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurodegenerative Disease Unit, Department of Neuroscience, Padua Neuroscience Center (PNC), University of Padua, Padua, Italy.
- Department of Medicine-DIMED, University of Padua, Padua, Italy.
- Laboratory Medicine, University-Hospital of Padua, Padua, Italy.
- Department of General Psychology, University of Padua, Padua, Italy.
- IRCCS San Camillo Hospital, Venice, Italy.
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm, University, Aging Research Center, Stockholm, Sweden.
ORCID-Profile: Renzo Manara, Angelo Antonini
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca, National Recovery and Resilience Plan (NRRP).
- NextGenerationEU (DM 1557 11.10.2022).
Zitieren
APA
Fiorenzato, E., Cauzzo, S., Musso, G., Biundo, R., Ceolin, C., Cosma, C., Fogliano, C. A., Meissner, W. G., Misenti, V., Moz, S., Nasi, M. L., Vianello, F., Manara, R., Montagnana, M., Sergi, G., Antonini, A., & OPA Working Group (2026). Plasma p‐tau217 Versus p‐tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease‐Related Neurostructural Changes and Cognitive Function. Movement Disorders. https://doi.org/10.1002/mds.70392
Vancouver
Fiorenzato E, Cauzzo S, Musso G, Biundo R, Ceolin C, Cosma C, et al. Plasma p‐tau217 Versus p‐tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease‐Related Neurostructural Changes and Cognitive Function. Movement Disorders. 2026. doi:10.1002/mds.70392
BibTeX
@article{Fiorenzato2026,
author = {Fiorenzato, Eleonora and Cauzzo, Simone and Musso, Giulia and Biundo, Roberta and Ceolin, Chiara and Cosma, Chiara and Fogliano, Carmelo Alessandro and Meissner, Wassilios G and Misenti, Valentina and Moz, Stefania and Nasi, Maria Laura and Vianello, Francesca and Manara, Renzo and Montagnana, Martina and Sergi, Giuseppe and Antonini, Angelo and OPA Working Group, OPA Working Group},
title = {Plasma p‐tau217 Versus p‐tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease‐Related Neurostructural Changes and Cognitive Function},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70392}
}
EUVIMED